Paolo Carminati

This inventor holds 37 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 8 EPO patents, primarily in Cancer Treatment. Top assignees: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., Sanofi, Farmitalia Carlo Erba S.r.l.. Active years: 1983-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paolo Carminati. Retrieved from https://idiyas.com/inventor/paolo-carminati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 6)

% Patents Active = 45.9

CIPO Patents = 6

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 139(Granted Patents)

Location History:

Pomezia, IT (2001 - 2011)
Rome, IT (2010 - 2012)
Milan, IT (1983 - 2016)

Company Filing History:

16 out of 343

Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.

Farmitalia Carlo Erba S.r.l.

patents

4. 3 out of 5

Metheresis Translational Research Sa

patents

5. 1 out of 4

Sciclone Pharmaceuticals International, Ltd.

patents

6. 1 out of 21

Sciclone Pharmaceuticals, Inc.

Sigma-Tau Farmaceutiche Riunite, S.p.a.

12. 1 out of 834,453

Other

patents

Years Active: 1983-2016

Loading Chart...

Areas of Expertise:

HGFR Binding Site

Cancer Metastasis

Pediatric Tumors

Fungal Infections

Antitumor Activities

Viral Diseases

Thymosin Alpha 1

Camptothecin Derivatives

Diabetes Prevention

Anti-inflammatory Agents

Pharmaceutical Compositions

Anorectic Agents

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9310377 - High affinity binding site of HGFR and methods for identification of antagonists thereof (2016-04-12),

2. 9121854 - Method for treating cancer or cancer metastasis (2015-09-01),

3. 8829021 - Treatment of pediatric tumors (2014-09-09),

4. 8778389 - Medicament for the treatment of fungal infections particularly aspergillosis (2014-07-15),

5. 8404453 - High affinity binding site of HGFR and methods for identification of antagonists thereof (2013-03-26),

6. 8389574 - Method useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance (2013-03-05),

7. 8383616 - Aryl isoxazole compounds with antitumoural activities (2013-02-26),

8. 8268304 - Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases (2012-09-18),

9. 8124769 - Stereoselective process and crystalline forms of a camptothecin (2012-02-28),

10. 8101758 - Stereoselective process and crystalline forms of a camptothecin (2012-01-24),

11. 8029799 - Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma (2011-10-04),

12. 8017129 - Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma (2011-09-13),

13. 7989171 - Anti-human tenascin monoclonal antibody (2011-08-02),

14. 7935346 - Medicament for the two-step perioperative therapy of solid tumours (2011-05-03),

15. 7910092 - Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases (2011-03-22),

Title: Paolo Carminati - Innovative Inventor from Milan

Introduction: Paolo Carminati is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Paolo Carminati's latest patents include advancements in renewable energy technologies, medical devices, and sustainable materials, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Paolo Carminati has established himself as a pioneer in the world of inventions, with numerous successful patents that have significantly impacted industries worldwide.

Collaborations: Paolo Carminati has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence in the process.

Conclusion: Paolo Carminati's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, making him a true visionary in the world of inventions.

Profile summary based on public USPTO records.